Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |